Loading…

Breast Cancer Subtypes in Patients Aged 70 Years and Older

Recurrence and survival pattern in breast cancer (bc) patients (pts) ≥ 70 years subcategorized according to subtype and age are still an area of uncertainty. Tumor characteristics, patient demographics, therapies applied, and recurrence pattern were compared between luminal A (LA), luminal B (LB), H...

Full description

Saved in:
Bibliographic Details
Published in:Cancer investigation 2016-05, Vol.34 (5), p.197-204
Main Authors: Königsberg, Robert, Pfeiler, Georg, Hammerschmid, Nicole, Holub, Oliver, Glössmann, Kerstin, Larcher-Senn, Julian, Dittrich, Christian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913
cites cdi_FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913
container_end_page 204
container_issue 5
container_start_page 197
container_title Cancer investigation
container_volume 34
creator Königsberg, Robert
Pfeiler, Georg
Hammerschmid, Nicole
Holub, Oliver
Glössmann, Kerstin
Larcher-Senn, Julian
Dittrich, Christian
description Recurrence and survival pattern in breast cancer (bc) patients (pts) ≥ 70 years subcategorized according to subtype and age are still an area of uncertainty. Tumor characteristics, patient demographics, therapies applied, and recurrence pattern were compared between luminal A (LA), luminal B (LB), Her2/neu overexpressing (Her+) and triple-negative (TN) bc subtypes and the age subcategories 70-74, 75-79, ≥80 years. Based on univariate Cox-regression-analyses distant-disease-free-survival (DDFS) differed significantly for bc subtypes (p = 0.0002), notably for Her+ vs. LA (p = 0.0014), TN vs. LA (p < 0.001), and TN vs. LB (p = 0.0086). Not age, but Her+ and TN represented prognostic factors for DDFS.
doi_str_mv 10.1080/07357907.2016.1182184
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_27215407</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1793566111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913</originalsourceid><addsrcrecordid>eNp90D1PwzAQgGELgWgp_ASQR5YU27HjhIlS8SVVKhIwMFmX-IyC8lHsRKj_nkQtjEy3PHcnvYScczbnLGVXTMdKZ0zPBePJnPNU8FQekClXsYgkz8QhmY4mGtGEnITwydigtDomE6EFV5LpKbm-9Qiho0toCvT0pc-77QYDLRv6DF2JTRfo4gMt1Yy-I_hAobF0XVn0p-TIQRXwbD9n5O3-7nX5GK3WD0_LxSoq4iTpohykTHJkkKCMZZajLTLlYoZOgNVS5AIAi0LnVkmneeJQQmYFqNQ6lWY8npHL3d2Nb796DJ2py1BgVUGDbR8M11mskoTzkaodLXwbgkdnNr6swW8NZ2bMZn6zmTGb2Wcb9i72L_q8Rvu39dtpADc7UDau9TV8t76ypoNt1Xrnh3ZlMPH_P34A4DJ66A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1793566111</pqid></control><display><type>article</type><title>Breast Cancer Subtypes in Patients Aged 70 Years and Older</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Königsberg, Robert ; Pfeiler, Georg ; Hammerschmid, Nicole ; Holub, Oliver ; Glössmann, Kerstin ; Larcher-Senn, Julian ; Dittrich, Christian</creator><creatorcontrib>Königsberg, Robert ; Pfeiler, Georg ; Hammerschmid, Nicole ; Holub, Oliver ; Glössmann, Kerstin ; Larcher-Senn, Julian ; Dittrich, Christian</creatorcontrib><description>Recurrence and survival pattern in breast cancer (bc) patients (pts) ≥ 70 years subcategorized according to subtype and age are still an area of uncertainty. Tumor characteristics, patient demographics, therapies applied, and recurrence pattern were compared between luminal A (LA), luminal B (LB), Her2/neu overexpressing (Her+) and triple-negative (TN) bc subtypes and the age subcategories 70-74, 75-79, ≥80 years. Based on univariate Cox-regression-analyses distant-disease-free-survival (DDFS) differed significantly for bc subtypes (p = 0.0002), notably for Her+ vs. LA (p = 0.0014), TN vs. LA (p &lt; 0.001), and TN vs. LB (p = 0.0086). Not age, but Her+ and TN represented prognostic factors for DDFS.</description><identifier>ISSN: 0735-7907</identifier><identifier>EISSN: 1532-4192</identifier><identifier>DOI: 10.1080/07357907.2016.1182184</identifier><identifier>PMID: 27215407</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>adjuvant therapies ; Age categories ; Age Factors ; Aged ; Aged, 80 and over ; Biomarkers, Tumor ; breast cancer subtypes ; Breast Neoplasms - diagnosis ; Breast Neoplasms - mortality ; Breast Neoplasms - therapy ; Combined Modality Therapy ; DDFS ; Elderly patients ; Female ; Humans ; Immunohistochemistry ; LRFS ; Neoplasm Grading ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Retrospective Studies ; Treatment Outcome ; Tumor Burden</subject><ispartof>Cancer investigation, 2016-05, Vol.34 (5), p.197-204</ispartof><rights>2016 Taylor &amp; Francis Group, LLC 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913</citedby><cites>FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27215407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Königsberg, Robert</creatorcontrib><creatorcontrib>Pfeiler, Georg</creatorcontrib><creatorcontrib>Hammerschmid, Nicole</creatorcontrib><creatorcontrib>Holub, Oliver</creatorcontrib><creatorcontrib>Glössmann, Kerstin</creatorcontrib><creatorcontrib>Larcher-Senn, Julian</creatorcontrib><creatorcontrib>Dittrich, Christian</creatorcontrib><title>Breast Cancer Subtypes in Patients Aged 70 Years and Older</title><title>Cancer investigation</title><addtitle>Cancer Invest</addtitle><description>Recurrence and survival pattern in breast cancer (bc) patients (pts) ≥ 70 years subcategorized according to subtype and age are still an area of uncertainty. Tumor characteristics, patient demographics, therapies applied, and recurrence pattern were compared between luminal A (LA), luminal B (LB), Her2/neu overexpressing (Her+) and triple-negative (TN) bc subtypes and the age subcategories 70-74, 75-79, ≥80 years. Based on univariate Cox-regression-analyses distant-disease-free-survival (DDFS) differed significantly for bc subtypes (p = 0.0002), notably for Her+ vs. LA (p = 0.0014), TN vs. LA (p &lt; 0.001), and TN vs. LB (p = 0.0086). Not age, but Her+ and TN represented prognostic factors for DDFS.</description><subject>adjuvant therapies</subject><subject>Age categories</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers, Tumor</subject><subject>breast cancer subtypes</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - therapy</subject><subject>Combined Modality Therapy</subject><subject>DDFS</subject><subject>Elderly patients</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>LRFS</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Recurrence, Local</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Tumor Burden</subject><issn>0735-7907</issn><issn>1532-4192</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp90D1PwzAQgGELgWgp_ASQR5YU27HjhIlS8SVVKhIwMFmX-IyC8lHsRKj_nkQtjEy3PHcnvYScczbnLGVXTMdKZ0zPBePJnPNU8FQekClXsYgkz8QhmY4mGtGEnITwydigtDomE6EFV5LpKbm-9Qiho0toCvT0pc-77QYDLRv6DF2JTRfo4gMt1Yy-I_hAobF0XVn0p-TIQRXwbD9n5O3-7nX5GK3WD0_LxSoq4iTpohykTHJkkKCMZZajLTLlYoZOgNVS5AIAi0LnVkmneeJQQmYFqNQ6lWY8npHL3d2Nb796DJ2py1BgVUGDbR8M11mskoTzkaodLXwbgkdnNr6swW8NZ2bMZn6zmTGb2Wcb9i72L_q8Rvu39dtpADc7UDau9TV8t76ypoNt1Xrnh3ZlMPH_P34A4DJ66A</recordid><startdate>20160527</startdate><enddate>20160527</enddate><creator>Königsberg, Robert</creator><creator>Pfeiler, Georg</creator><creator>Hammerschmid, Nicole</creator><creator>Holub, Oliver</creator><creator>Glössmann, Kerstin</creator><creator>Larcher-Senn, Julian</creator><creator>Dittrich, Christian</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160527</creationdate><title>Breast Cancer Subtypes in Patients Aged 70 Years and Older</title><author>Königsberg, Robert ; Pfeiler, Georg ; Hammerschmid, Nicole ; Holub, Oliver ; Glössmann, Kerstin ; Larcher-Senn, Julian ; Dittrich, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>adjuvant therapies</topic><topic>Age categories</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers, Tumor</topic><topic>breast cancer subtypes</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - therapy</topic><topic>Combined Modality Therapy</topic><topic>DDFS</topic><topic>Elderly patients</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>LRFS</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Recurrence, Local</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Tumor Burden</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Königsberg, Robert</creatorcontrib><creatorcontrib>Pfeiler, Georg</creatorcontrib><creatorcontrib>Hammerschmid, Nicole</creatorcontrib><creatorcontrib>Holub, Oliver</creatorcontrib><creatorcontrib>Glössmann, Kerstin</creatorcontrib><creatorcontrib>Larcher-Senn, Julian</creatorcontrib><creatorcontrib>Dittrich, Christian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Königsberg, Robert</au><au>Pfeiler, Georg</au><au>Hammerschmid, Nicole</au><au>Holub, Oliver</au><au>Glössmann, Kerstin</au><au>Larcher-Senn, Julian</au><au>Dittrich, Christian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Breast Cancer Subtypes in Patients Aged 70 Years and Older</atitle><jtitle>Cancer investigation</jtitle><addtitle>Cancer Invest</addtitle><date>2016-05-27</date><risdate>2016</risdate><volume>34</volume><issue>5</issue><spage>197</spage><epage>204</epage><pages>197-204</pages><issn>0735-7907</issn><eissn>1532-4192</eissn><abstract>Recurrence and survival pattern in breast cancer (bc) patients (pts) ≥ 70 years subcategorized according to subtype and age are still an area of uncertainty. Tumor characteristics, patient demographics, therapies applied, and recurrence pattern were compared between luminal A (LA), luminal B (LB), Her2/neu overexpressing (Her+) and triple-negative (TN) bc subtypes and the age subcategories 70-74, 75-79, ≥80 years. Based on univariate Cox-regression-analyses distant-disease-free-survival (DDFS) differed significantly for bc subtypes (p = 0.0002), notably for Her+ vs. LA (p = 0.0014), TN vs. LA (p &lt; 0.001), and TN vs. LB (p = 0.0086). Not age, but Her+ and TN represented prognostic factors for DDFS.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>27215407</pmid><doi>10.1080/07357907.2016.1182184</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0735-7907
ispartof Cancer investigation, 2016-05, Vol.34 (5), p.197-204
issn 0735-7907
1532-4192
language eng
recordid cdi_pubmed_primary_27215407
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects adjuvant therapies
Age categories
Age Factors
Aged
Aged, 80 and over
Biomarkers, Tumor
breast cancer subtypes
Breast Neoplasms - diagnosis
Breast Neoplasms - mortality
Breast Neoplasms - therapy
Combined Modality Therapy
DDFS
Elderly patients
Female
Humans
Immunohistochemistry
LRFS
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Proportional Hazards Models
Retrospective Studies
Treatment Outcome
Tumor Burden
title Breast Cancer Subtypes in Patients Aged 70 Years and Older
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A27%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Breast%20Cancer%20Subtypes%20in%20Patients%20Aged%2070%20Years%20and%20Older&rft.jtitle=Cancer%20investigation&rft.au=K%C3%B6nigsberg,%20Robert&rft.date=2016-05-27&rft.volume=34&rft.issue=5&rft.spage=197&rft.epage=204&rft.pages=197-204&rft.issn=0735-7907&rft.eissn=1532-4192&rft_id=info:doi/10.1080/07357907.2016.1182184&rft_dat=%3Cproquest_pubme%3E1793566111%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-ba446be0a6e4349bedc95f30ef2ad742b2aaecc7bd54f716fe4a9d2a58df58913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1793566111&rft_id=info:pmid/27215407&rfr_iscdi=true